目的 对含邻苯二甲酸酯类增塑剂药包材的添加剂进行安全性评估,为药包材相容性研究提供帮助。方法 从两方面对邻苯二甲酸酯类增塑剂进行安全性研究。一方面,通过检索数据库或收集美国及欧洲官方网站公布的部分邻苯二甲酸酯类增塑剂口服途径的毒理学数据,推测该物质的每日最大暴露量。另一方面,采用毒理学软件Toxtree中“Cramer决策树”对无法获得每日最大暴露量的邻苯二甲酸酯类增塑剂进行安全性研究。结果 通过文献收集得到11个邻苯二甲酸酯类增塑剂口服途径的安全性评估数据,采用毒理学软件分析得到8个邻苯二甲酸酯类增塑剂口服途径的安全性评估数据。结论 建立了19个邻苯二甲酸酯类物质口服途径的安全性评估数据,为药包材相容性研究提供安全性数据支撑。
Abstract
OBJECTIVE To provide information for the compatibility study between pharmaceutical packing materials and drugs by assessing safety of phthalate esters (PAEs). METHODS This study of phthalate esters was carried out from two aspects. On the one hand, were retrieved databases and searched relevant official literatures of USA and Europe, and then transformed the obtained knowledge to permitted daily exposure (PDE) in oral administration. On the other hand, Toxtree v3.1.0 software was used to get the safety data of those PAEs for which PDE data was not available. RESULTS The PDE values and the safety concern threshold (SCT) were obtained for 11 and 8 PAEs compounds by official literatures and Toxtree software, respectively. CONCLUSION The safety data is established for 19 PAEs given by oral administration, which could provide help for the compatibility study between pharmaceutical packing materials and drugs.
关键词
安全性评估 /
邻苯二甲酸酯 /
人每日允许最大暴露量 /
安全性阈值 /
相容性研究
{{custom_keyword}} /
Key words
safety assessment /
PAEs /
PDE /
SCT /
compatibility study
{{custom_keyword}} /
中图分类号：
R917
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] CFDA. Guidance of compatibility study of injections and plastic packaging materials(化学药品注射剂与塑料包装材料相容性研究技术指导原则). 2012.
[2] SOPHEAK N,RICHARD S, ANNE D, et al.Occurrence, fate, behavior and ecotoxicological state of phthalatesin different environmental matrices. Environ Sci Technol, 2015, 49(7):4019-4035.
[3] ZENG F, CUI K Y, XIE Z Y, et al. Phthalate esters (PAEs):Emerging organic contaminants in agricultural soils in peri-urban areas around Guangzhou, China. Environ Pollut, 2008, 156(2):425-434.
[4] JIN D, KONG X, CUI B, et al. Biodegradation of di-n-butyl phthalate by a newly isolated halotolerant sphingobiumsp. Int J Mol Sci, 2013,14(12):24046-24054.
[5] EP,No 2020/2096 amending REACH ANNEX XVⅡ.2020:31-34.
[6] JIANG Y, MA L, MA Y, et al. Application of the threshold of toxicological concern to the research and evaluation of the compatibility of drug products and container systems. Chin J Pharm(中国医药工业杂志),2016,47(7):946-951.
[7] EFSA. Update of the risk assessment of di-butylphthalate (DBP),butyl-benzyl-phthalate(BBP), bis(2-ethylhexyl)phthalate(DEHP), di-isononylphthalate (DINP) and diisodecylphthalate(DIDP) for use in food contact materials.2019,10.2903/j.efsa.2019.5838.
[8] ICH.Q3C(R5).Guideline for residual solvents.2011:15-17.
[9] JIANG Y, MA Y, HUO X, et al. Interpretation of the guidance of compatibility study of injections and plastic packaging materials-extract and migration study design.Chin New Drugs J(中国新药杂志),2014,23(15):1738-1748.
[10] PPRTVs. Dimethylphthalate.2007,. https://hhpprtv.ornl.gov/issue_papers/Dimethylphthalate.pdf.
[11] IRIS. Diethyl phthalate.1987,. https://iris.epa.gov/static/pdfs/0226_summary.pdf.
[12] ATSDR. Toxicological profile for diethyl phthalate.1993,. https://www.atsdr.cdc.gov/ToxProfiles/tp73.pdf.
[13] HPV.Diallylphthalate.2004,.https://hpvchemicals.oecd.org/UI/handler.axd?id=7d43c4ed-50b4-43e7-b2fc-93fc2f3ad6d7.
[14] HPV. 1,2-Benzenedicarboxylic acid, bis(2-methoxyethyl) ester (Di(methoxyethyl)phthalate). 2009,. https://hpvchemicals.oecd.org/UI/handler.axd?id=9c62ed8f-8c68-41a4-a1b9-8ca7677ef5bb.
[15] CPSC. Toxicity Review for Dicyclohexyl Phthalate. 2011,. https://www.cpsc.gov/s3fs-public/dchp.pdf
[16] ATSDR. Toxicological Profile for DI-n-octylphthalate. 1997,. https://www.atsdr.cdc.gov/toxprofiles/tp95.pdf.
[17] THOMAS H B, SUSANNE G, UMA S B, et al. Assessing safety of extractables from materials and leachables in pharmaceuticalsand biologics-Current challenges and approaches.Regul Toxicol Pharmacol, 2016, 81:201-211.
[18] ZHUANG J, XING X, WANG D, et al. Toxicity assessment of the extractables from multi-layer coextrusion polyethylene bags exposed to pH=5 solution containing 4% benzyl alcohol and 0.1M sodium acetate. Regul Toxicol Pharmacol, 2018, 94:47-56.
[19] WANG D D, LI X L, ZHU Y H, et al. Compatibility between medicinal rubber stoppers and 13-valent pneumococcal polysaccharide conjugate vaccine by HPLC-DAD-CAD. Chin Pharm J(中国药学杂志), 2022, 57(3):220-226.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
PDF(1127 KB)
